G Mason Morfit, a director at $CRM, bought 96,000 shares of the company on 12-05-2025 for an estimated $25,015,680. This trade was reported by Quiver Quantitative using data from a recent SEC filing. This increased their holdings of this class of stock by approximately 3.3%. Following this trade, they now own 2,994,509 shares of this class of $CRM stock.
$CRM Insider Trading Activity
$CRM insiders have traded $CRM stock on the open market 494 times in the past 6 months. Of those trades, 2 have been purchases and 492 have been sales.
Here’s a breakdown of recent trading of $CRM stock by insiders over the last 6 months:
- MARC BENIOFF (Chair and CEO) has made 0 purchases and 479 sales selling 195,872 shares for an estimated $49,201,838.
- PARKER HARRIS (Co-Founder and CTO, Slack) has made 0 purchases and 7 sales selling 135,804 shares for an estimated $31,904,632.
- G MASON MORFIT purchased 96,000 shares for an estimated $25,015,680
- DAVID BLAIR KIRK purchased 3,400 shares for an estimated $865,827
- SRINIVAS TALLAPRAGADA (Chief Eng/Cust Success Officer) has made 0 purchases and 2 sales selling 1,269 shares for an estimated $332,919.
- SABASTIAN NILES (President and CLO) sold 569 shares for an estimated $149,275
- MIGUEL MILANO (President and CRO) sold 405 shares for an estimated $106,250
- SUNDEEP G. REDDY (EVP & Chief Accounting Officer) has made 0 purchases and 2 sales selling 261 shares for an estimated $68,472.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$CRM Hedge Fund Activity
We have seen 1,341 institutional investors add shares of $CRM stock to their portfolio, and 1,665 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- CAPITAL WORLD INVESTORS added 10,636,161 shares (+159.0%) to their portfolio in Q3 2025, for an estimated $2,520,770,157
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC added 6,395,250 shares (+60.8%) to their portfolio in Q3 2025, for an estimated $1,515,674,250
- WELLINGTON MANAGEMENT GROUP LLP removed 5,283,162 shares (-85.2%) from their portfolio in Q3 2025, for an estimated $1,252,109,394
- ROCKEFELLER CAPITAL MANAGEMENT L.P. added 4,803,672 shares (+698.2%) to their portfolio in Q3 2025, for an estimated $1,138,470,264
- JPMORGAN CHASE & CO removed 4,771,344 shares (-26.8%) from their portfolio in Q3 2025, for an estimated $1,130,808,528
- HARRIS ASSOCIATES L P added 4,053,994 shares (+135.5%) to their portfolio in Q3 2025, for an estimated $960,796,578
- FRANKLIN RESOURCES INC removed 3,808,568 shares (-54.2%) from their portfolio in Q3 2025, for an estimated $902,630,616
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$CRM Revenue
$CRM had revenues of $10.3B in Q3 2026. This is an increase of 8.63% from the same period in the prior year.
You can track CRM financials on Quiver Quantitative's CRM stock page.
$CRM Congressional Stock Trading
Members of Congress have traded $CRM stock 10 times in the past 6 months. Of those trades, 5 have been purchases and 5 have been sales.
Here’s a breakdown of recent trading of $CRM stock by members of Congress over the last 6 months:
- REPRESENTATIVE VAL T. HOYLE has traded it 2 times. They made 1 purchase worth up to $15,000 on 06/26 and 1 sale worth up to $15,000 on 09/23.
- REPRESENTATIVE DAVID TAYLOR has traded it 3 times. They made 3 purchases worth up to $45,000 on 09/03, 08/07, 06/11 and 0 sales.
- REPRESENTATIVE LISA C. MCCLAIN has traded it 3 times. They made 1 purchase worth up to $15,000 on 06/17 and 2 sales worth up to $30,000 on 07/16.
- REPRESENTATIVE RITCHIE TORRES sold up to $15,000 on 07/11.
- REPRESENTATIVE JAMES COMER sold up to $15,000 on 07/03.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
$CRM Analyst Ratings
Wall Street analysts have issued reports on $CRM in the last several months. We have seen 13 firms issue buy ratings on the stock, and 1 firms issue sell ratings.
Here are some recent analyst ratings:
- Baird issued a "Outperform" rating on 12/04/2025
- Needham issued a "Buy" rating on 12/04/2025
- Wedbush issued a "Outperform" rating on 12/04/2025
- Citizens issued a "Market Outperform" rating on 12/04/2025
- BMO Capital issued a "Outperform" rating on 12/04/2025
- Oppenheimer issued a "Outperform" rating on 12/01/2025
- Cantor Fitzgerald issued a "Overweight" rating on 11/25/2025
To track analyst ratings and price targets for $CRM, check out Quiver Quantitative's $CRM forecast page.
$CRM Price Targets
Multiple analysts have issued price targets for $CRM recently. We have seen 29 analysts offer price targets for $CRM in the last 6 months, with a median target of $315.0.
Here are some recent targets:
- Gil Luria from DA Davidson set a target price of $235.0 on 12/05/2025
- Patrick Walravens from Citizens set a target price of $405.0 on 12/04/2025
- Steve Koenig from Macquarie set a target price of $265.0 on 12/04/2025
- Keith Bachman from BMO Capital set a target price of $275.0 on 12/04/2025
- Scott Berg from Needham set a target price of $400.0 on 12/04/2025
- Kirk Materne from Evercore ISI Group set a target price of $340.0 on 12/04/2025
- Brad Zelnick from Deutsche Bank set a target price of $360.0 on 12/04/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
